Trials / Conditions / Idiopathic Multicentric Castleman's Disease
Idiopathic Multicentric Castleman's Disease
4 registered clinical trials studyying Idiopathic Multicentric Castleman's Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Producing a Novel Symptom Burden Scale for People Living With Idiopathic Multicentric Castleman Disease (ISBUS NCT05995834 | RECORDATI GROUP | — |
| Terminated | Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease NCT04838860 | RECORDATI GROUP | Phase 2 |
| Unknown | Zanuburutinib in Relapsed and Refractory iMCD: a Prospective, Single-center, Single-arm Trial NCT04743687 | Peking Union Medical College Hospital | Phase 2 |
| Unknown | BCD Regimen in Newly Diagnosed Idiopathic Multicentric Castleman's Disease (iMCD) NCT03982771 | Peking Union Medical College Hospital | Phase 2 |